Publication:
The Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells

dc.contributor.authorDoymaz M. Z.
dc.contributor.authorAydın B. N.
dc.contributor.authorÇetin N. S.
dc.contributor.authorKaygusuz A.
dc.contributor.institutionauthorDOYMAZ, MEHMET ZIYA
dc.contributor.institutionauthorÇETİN, NESİBE SELMA
dc.date.accessioned2023-01-08T22:40:10Z
dc.date.available2023-01-08T22:40:10Z
dc.date.issued2022-10-20
dc.identifier.citationDoymaz M. Z., Aydın B. N., Çetin N. S., Kaygusuz A., \"The Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells\", 5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V) Scientific Programme, İzmir, Türkiye, 20 - 22 Ekim 2022, ss.38
dc.identifier.urihttps://hdl.handle.net/20.500.12645/34794
dc.relation.ispartof5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V) Scientific Programme
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectLife Sciences
dc.subjectNatural Sciences
dc.subjectTemel Bilimler (SCI)
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectDoğa Bilimleri Genel
dc.subjectÇOK DİSİPLİNLİ BİLİMLER
dc.subjectNatural Sciences (SCI)
dc.subjectLife Sciences (LIFE)
dc.subjectNATURAL SCIENCES, GENERAL
dc.subjectMULTIDISCIPLINARY SCIENCES
dc.subjectMultidisipliner
dc.subjectMultidisciplinary
dc.titleThe Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells
dc.typeconferenceObject
dspace.entity.typePublication
local.avesis.id12b4fc13-c999-43a9-8e89-f8f4b0bc8de0
relation.isAuthorOfPublicationf0c7c3b7-2961-49ef-bb8b-63dd8654c929
relation.isAuthorOfPublication81f75849-99c2-4a67-9c66-426976a917ed
relation.isAuthorOfPublication.latestForDiscoveryf0c7c3b7-2961-49ef-bb8b-63dd8654c929

Files